Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease

Details for Australian Patent Application No. 2002338716 (hide)

Owner TopoTarget Gemany AG

Inventors Heinzel, Thorsten; Herrlich, Peter A; Hentsch, Bernd; Gottlicher, Martin; Groner, Bernd; Minucci, Saverio; Wels, Winfried Stephan; Pelicci, Pier Giuseppe

Agent Davies Collison Cave

Pub. Number AU-B-2002338716

PCT Number PCT/EP02/10419

PCT Pub. Number WO2003/024442

Priority 01121722.1 18.09.01 EP

Filing date 17 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 16 August 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/19 (2006.01)

A61K 31/20 (2006.01)

A61K 31/203 (2006.01)

A61K 31/28 (2006.01) - Compounds containing heavy metals

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61K 31/593 (2006.01)

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 01121722.1 18.09.01 EP

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002338716

16 August 2007 Application Accepted

  Published as AU-B-2002338716

23 August 2007 Change of Name(s) of Applicant(s), Section 104

  G2M Cancer Drugs AG The name of the applicant has been changed to TopoTarget Germany AG

13 December 2007 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002338717-METHOD FOR DETERMINING PROBABILITIES, ABOVE ALL IN MEDICAL FIELDS AND DEVICE FOR THE ABOVE

2002338715-DOSING DEVICE FOR SANDING DEVICES, ESPECIALLY FOR RAIL VEHICLES